AI assistant
Sending…
Vericel Corp — Director's Dealing 2011
Oct 24, 2011
31799_dirs_2011-10-24_97fcd9df-5061-4087-8ece-e76675da5cdf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2011-10-13
Reporting Person: Gibson Brian (Vice President)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.48 | 2020-07-14 | Common Stock (70000) | Direct | |
| Stock Option (right to buy) | $1.49 | 2020-09-22 | Common Stock (5000) | Direct | |
| Stock Option (right to buy) | $2.26 | 2021-03-11 | Common Stock (70000) | Direct |
Footnotes
F1: These options were granted on July 14, 2010 with 25% vesting on the first anniversary of the date of grant and 6.25% vesting each quarter thereafter.
F2: These options were granted on September 22, 2010 and vest quarterly over four years commencing on the date of grant.
F3: These options were granted on March 11, 2011 and vest quarterly over four years commencing on the date of grant.
More from Vericel Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Annual Report
2026
Mar 19